Phase 2 clinical trial of the AVI-CO-004 tablet.
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2018
At a glance
- Drugs AVI CO 004 (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 20 Mar 2018 New trial record
- 03 Mar 2018 According to Ebixen media release, the Korea Food and Drug Administration (KFDA) approved AVI-CO-004 for phase 2 study.